Monohon Ted
SEC CIK 1606905 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | CAO, VP | 27.4K | — | $1,834 | 5 | 2022-03-03 | 2023-03-06 |
Most active insiders at QNCX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Benatti Luca | Dir | — | $173.5K |
| 2 | Hannah Brendan | COO, CCO, CBO | — | — |
| 3 | Thye Dirk | CEO, CMO, Dir | — | — |
Monohon Ted made no open-market trades at QNCX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-03-06 | QNCX | Quince Therapeutics, Inc. | Monohon Ted | CAO, VP | S - Sale | $0.98 | -1,871 | 27.4K | -6% | -$1,834 | |
| 2022-12-07 | 2022-12-05 | QNCX | Quince Therapeutics, Inc. | Monohon Ted | CAO, VP | F - Tax | $0.72 | -1,640 | 29.3K | -5% | -$1,181 | |
| 2022-09-08 | 2022-09-06 | QNCX | Quince Therapeutics, Inc. | Monohon Ted | CAO, VP | F - Tax | $1.64 | -1,520 | 31.0K | -5% | -$2,493 | |
| 2022-06-08 | 2022-06-06 | QNCX | Quince Therapeutics, Inc. | Monohon Ted | CAO, VP | F - Tax | $3.12 | -1,529 | 32.5K | -4% | -$4,770 | |
| 2022-03-04 | 2022-03-03 | QNCX | Quince Therapeutics, Inc. | Monohon Ted | CAO, VP | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations